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ABSTRACT 
 
Validated biomarkers are useful tools for screening large populations. The benefit of screening 
may be improved risk assessment or early indications of adverse effects before detection or onset 
of symptoms. Screening is valuable in studies of environmental exposures and their effects on 
human health, for example after exposure to air pollution and toxic metals in our daily 
environment. The overall aim of this thesis was to optimize sampling of urinary Clara cell 16 kDa 
protein (CC16) and alpha 1-microglobulin (A1M) and test them as biomarkers of changes in 
kidney and airway function.  
 
For optimized sampling of urinary CC16 and A1M, timed or creatinine-corrected first morning 
samples are preferable. This is the time of day when the variation in excretion due to influence of 
urine flow and daily activities is low. For all urinary CC16 sampling, men should discard the first 
100 ml to wash out post-renal excretion of CC16 before collection. 
 
Urinary and serum CC16 were tested as biomarkers of changes in the permeability of the 
respiratory epithelium. This was examined after exposure to wood smoke for 4 hours and 
compared with a session of filtered clean air for 4 hours. Exposure to wood smoke significantly 
increased serum CC16 after 20 hours and there was tendency towards increased urinary CC16.  
 
Both urinary CC16 and A1M are sensitive to changes in tubular function and were analysed 
together with another tubular biomarker, retinol-binding protein (RBP), in the urine of small 
children with urinary tract infection (UTI). Clara cell 16 kDa protein was significantly higher in 
children with upper UTI compared with children with lower UTI. Also, the association between 
decreased uptake of dimercaptosuccinic acid (DMSA) and increased excretion of CC16 was 
strong. There was no difference in A1M excretion between upper and lower UTI.  
 
In patients with community-acquired pneumonia (CAP), urinary CC16 was increased compared 
with the control group. By contrast, serum CC16 was decreased in patients with CAP. The 
increase in urinary CC16 was probably due to fever-related proteinuria since urinary A1M and 
RBP were also increased. The decrease in serum CC16 could be explained by increased renal 
excretion. Also, asthma, chronic obstructive pulmonary disease (COPD) and smoking (known to 
decrease serum CC16) were common among patients with CAP.  
 
In conclusion, this thesis demonstrates that both CC16 and A1M are useful biomarkers of tubular 
renal function. There is also a possibility to use urinary CC16 as an airway biomarker in 
screening studies of air pollution under the right conditions, using optimal sampling methods. 
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